Regulations.gov document
Meeting Request and Briefing Document Benzethonium Chloride (BZT) - In Vivo Efficacy
Other · FDA-2015-N-0101 · posted Dec 10, 2020
Key facts
| Document ID | FDA-2015-N-0101-1497 |
|---|---|
| Title | Meeting Request and Briefing Document Benzethonium Chloride (BZT) - In Vivo Efficacy |
| Document type | Other |
| Subtype | Brief |
| Agency | FDA |
| Docket | FDA-2015-N-0101 |
| Posted | Dec 10, 2020 |
| Comment period opens | Dec 10, 2020 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: